Targeting the mineralocorticoid receptor to reduce CKD in T2D: is it time for a new treatment paradigm?
- Rossing, P. (Lecturer)
Activity: Talk or presentation › Lecture and oral contribution
Activity: Talk or presentation › Lecture and oral contribution